Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Summary of Significant Accounting Policies [Line Items]
Percentage of research and development tax reimbursable	43.50%	43.50%	43.50%	43.50%
Research and development tax incentive receivable	$ 309,825		$ 309,825		$ 433,852
Research and development expenses	$ 121,709	$ 88,947	$ 347,972	$ 211,785
Common shares [Member]
Summary of Significant Accounting Policies [Line Items]
Warrants to purchase common stock (in Shares)	896,000		896,000
Exercise price (in Dollars per share)	$ 0.0001		$ 0.0001